Cargando…
Oncological patients' reactions to COVID‐19 pandemic: A single institution prospective study
BACKGROUND: The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. AIM: An analysis of cancer patients fears, and awareness of COVID‐19 has been done in this study. METHODS AND RESULTS: We analyzed cancer patients...
Autores principales: | Onesti, Concetta Elisa, Schroeder, Hélène, Rorive, Andrée, Sautois, Brieuc, Lecocq, Marie, Goffin, Marie, Gonne, Elodie, Collinge, Astrid, Nicolaers, Laurence, Wéra, Odile, Catot, Amandine, Loly, Catherine, Paulus, Astrid, Sibille, Anne, Lousberg, Laurence, Troisfontaine, Florence, Collignon, Joëlle, Gennigens, Christine, Frères, Pierre, Polus, Marc, Duysinx, Bernard, Vaillant, Frédérique, Marchal, Nathalie, Poncin, Aurélie, Jerusalem, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646835/ https://www.ncbi.nlm.nih.gov/pubmed/34636178 http://dx.doi.org/10.1002/cnr2.1571 |
Ejemplares similares
-
1720P How do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium
por: Onesti, C.E., et al.
Publicado: (2020) -
1712P Risk of SARS-CoV-2 infection and outcome after infection: Experience from the day-care unit at CHU Liège in Belgium
por: Lecocq, M., et al.
Publicado: (2020) -
Triple-negative breast cancer: treatment challenges and solutions
por: Collignon, Joëlle, et al.
Publicado: (2016) -
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
por: Onesti, Concetta Elisa, et al.
Publicado: (2018) -
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer
por: Lousberg, Laurence, et al.
Publicado: (2017)